Chimin Health Management Co., Ltd. (603222.SS)
CNY 5.97
(0.67%)
CNY 5.97
(0.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 378.8 Million CNY | -2.05% |
| 2022 | 387.5 Million CNY | -26.58% |
| 2021 | 527.79 Million CNY | 46.48% |
| 2020 | 360.31 Million CNY | 2.54% |
| 2019 | 351.39 Million CNY | 21.27% |
| 2018 | 289.76 Million CNY | 6.79% |
| 2017 | 271.33 Million CNY | 32.56% |
| 2016 | 204.69 Million CNY | -5.77% |
| 2015 | 217.21 Million CNY | -7.8% |
| 2014 | 235.59 Million CNY | -15.38% |
| 2013 | 278.41 Million CNY | 1.04% |
| 2012 | 275.55 Million CNY | 7.59% |
| 2011 | 256.11 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 99.5 Million CNY | 22.63% |
| 2024 Q2 | 104.24 Million CNY | 4.76% |
| 2024 Q3 | 85.62 Million CNY | -17.86% |
| 2023 Q1 | 104.68 Million CNY | 24.61% |
| 2023 Q2 | 94.92 Million CNY | -9.32% |
| 2023 Q3 | 98.8 Million CNY | 4.09% |
| 2023 Q4 | 81.14 Million CNY | -17.87% |
| 2023 FY | 379.55 Million CNY | -2.05% |
| 2022 Q2 | 60.16 Million CNY | -60.67% |
| 2022 Q1 | 152.97 Million CNY | -3.98% |
| 2022 FY | 387.5 Million CNY | -26.58% |
| 2022 Q4 | 84 Million CNY | -7.02% |
| 2022 Q3 | 90.35 Million CNY | 50.17% |
| 2021 Q3 | 117.53 Million CNY | -9.33% |
| 2021 Q4 | 159.32 Million CNY | 35.56% |
| 2021 FY | 527.79 Million CNY | 46.48% |
| 2021 Q2 | 129.62 Million CNY | 6.85% |
| 2021 Q1 | 121.31 Million CNY | 21.24% |
| 2020 Q4 | 100.06 Million CNY | -17.41% |
| 2020 FY | 360.31 Million CNY | 2.54% |
| 2020 Q1 | 48.24 Million CNY | -48.07% |
| 2020 Q2 | 90.84 Million CNY | 88.31% |
| 2020 Q3 | 121.15 Million CNY | 33.36% |
| 2019 Q2 | 82.66 Million CNY | 1.63% |
| 2019 FY | 351.39 Million CNY | 21.27% |
| 2019 Q1 | 81.33 Million CNY | 70.44% |
| 2019 Q3 | 94.49 Million CNY | 14.31% |
| 2019 Q4 | 92.89 Million CNY | -1.7% |
| 2018 Q4 | 47.72 Million CNY | -43.15% |
| 2018 Q3 | 83.93 Million CNY | -2.74% |
| 2018 Q2 | 86.3 Million CNY | 20.19% |
| 2018 Q1 | 71.8 Million CNY | 1.79% |
| 2018 FY | 289.76 Million CNY | 6.79% |
| 2017 FY | 271.33 Million CNY | 32.56% |
| 2017 Q4 | 70.53 Million CNY | -7.2% |
| 2017 Q3 | 76.01 Million CNY | 11.8% |
| 2017 Q1 | 56.78 Million CNY | 2.16% |
| 2017 Q2 | 67.99 Million CNY | 19.73% |
| 2016 Q1 | 44.91 Million CNY | -11.32% |
| 2016 Q3 | 57.51 Million CNY | 23.25% |
| 2016 Q4 | 55.59 Million CNY | -3.35% |
| 2016 Q2 | 46.66 Million CNY | 3.9% |
| 2016 FY | 204.69 Million CNY | -5.77% |
| 2015 Q1 | 56.05 Million CNY | 3.39% |
| 2015 Q2 | 52.5 Million CNY | -6.33% |
| 2015 Q3 | 58.01 Million CNY | 10.49% |
| 2015 Q4 | 50.64 Million CNY | -12.7% |
| 2015 FY | 217.21 Million CNY | -7.8% |
| 2014 Q3 | 61.28 Million CNY | -2.93% |
| 2014 Q4 | 54.21 Million CNY | -11.53% |
| 2014 Q1 | 56.96 Million CNY | 0.0% |
| 2014 FY | 235.59 Million CNY | -15.38% |
| 2014 Q2 | 63.13 Million CNY | 10.82% |
| 2013 FY | 278.41 Million CNY | 1.04% |
| 2012 FY | 275.55 Million CNY | 7.59% |
| 2011 FY | 256.11 Million CNY | 0.0% |